Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study
2012 ◽
Vol 48
(3)
◽
pp. 333-339
◽
2015 ◽
Vol 75
(5)
◽
pp. 1025-1035
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4601-4601
2014 ◽
Vol 21
(7)
◽
pp. 740-740
◽
2014 ◽
Vol 46
(4)
◽
pp. 339-347
◽